Insights

Niche Market Focus Tavotek specializes in developing therapeutic medicines for debilitating diseases with unmet medical needs, indicating a strong niche focus that could benefit from specialized biopharmaceutical supply chain, biotech infrastructure, and R&D collaboration services.

Innovation Potential With a recent funding of $35 million and a revenue range of $10 to 25 million, Tavotek is positioned for growth and innovation, creating opportunities for partnerships in technology integration, biotech equipment, and advanced manufacturing solutions.

Technology Adoption Utilizing modern web technologies and cloud services like Alibaba Cloud demonstrates Tavotek's investment in scalable, secure digital infrastructure, suggesting potential for collaboration on cloud-based R&D management or digital transformation initiatives.

Competitive Environment Compared to larger competitors with extensive employee bases and revenues, Tavotek's agility and focus on unmet medical needs offer opportunities for targeted outreach in personalized medicine, specialty biotech tools, and niche pharmaceutical solutions.

Growth Opportunities As a smaller but focused biopharmaceutical company with recent funding and R&D momentum, Tavotek may be receptive to strategic partnerships, investor relations tools, or outsourced manufacturing and research services to accelerate its development pipeline.

Similar companies to Tavotek Biotherapeutics

Tavotek Biotherapeutics Tech Stack

Tavotek Biotherapeutics uses 8 technology products and services including GoDaddy Website Builder, Lodash, Polyfill, and more. Explore Tavotek Biotherapeutics's tech stack below.

  • GoDaddy Website Builder
    Content Management System
  • Lodash
    Javascript Libraries
  • Polyfill
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • Wow
    Marketing Analytics
  • PHP
    Programming Languages
  • HTTP/3
    Web & Portal Technology
  • Alibaba Cloud
    Web Hosting

Media & News

Tavotek Biotherapeutics's Email Address Formats

Tavotek Biotherapeutics uses at least 1 format(s):
Tavotek Biotherapeutics Email FormatsExamplePercentage
First.Last@tavotek.comJohn.Doe@tavotek.com
48%
F.Last@tavotek.comJ.Doe@tavotek.com
2%
First.Last@tavotek.comJohn.Doe@tavotek.com
48%
F.Last@tavotek.comJ.Doe@tavotek.com
2%

Frequently Asked Questions

What is Tavotek Biotherapeutics's official website and social media links?

Minus sign iconPlus sign icon
Tavotek Biotherapeutics's official website is tavotek.com and has social profiles on LinkedInCrunchbase.

What is Tavotek Biotherapeutics's NAICS code?

Minus sign iconPlus sign icon
Tavotek Biotherapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Tavotek Biotherapeutics have currently?

Minus sign iconPlus sign icon
As of December 2025, Tavotek Biotherapeutics has approximately 14 employees across 2 continents, including North AmericaAsia. Key team members include Vp Of Molecular Biology: M. P. M.Head Of Biologics, Lead Scientist: S. T.Founder And Vice President Of Discovery Research: D. Z.. Explore Tavotek Biotherapeutics's employee directory with LeadIQ.

What industry does Tavotek Biotherapeutics belong to?

Minus sign iconPlus sign icon
Tavotek Biotherapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Tavotek Biotherapeutics use?

Minus sign iconPlus sign icon
Tavotek Biotherapeutics's tech stack includes GoDaddy Website BuilderLodashPolyfillSwiperWowPHPHTTP/3Alibaba Cloud.

What is Tavotek Biotherapeutics's email format?

Minus sign iconPlus sign icon
Tavotek Biotherapeutics's email format typically follows the pattern of First.Last@tavotek.com. Find more Tavotek Biotherapeutics email formats with LeadIQ.

How much funding has Tavotek Biotherapeutics raised to date?

Minus sign iconPlus sign icon
As of December 2025, Tavotek Biotherapeutics has raised $35M in funding. The last funding round occurred on Nov 18, 2021 for $35M.

Tavotek Biotherapeutics

Pharmaceutical ManufacturingPennsylvania, United States11-50 Employees

Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $35M

    Tavotek Biotherapeutics has raised a total of $35M of funding over 3 rounds. Their latest funding round was raised on Nov 18, 2021 in the amount of $35M.

  • $10M$25M

    Tavotek Biotherapeutics's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $35M

    Tavotek Biotherapeutics has raised a total of $35M of funding over 3 rounds. Their latest funding round was raised on Nov 18, 2021 in the amount of $35M.

  • $10M$25M

    Tavotek Biotherapeutics's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.